Do dried blood spots have the potential to support result management processes in routine sports drug testing? - Part 2: Proactive sampling for follow-up investigations concerning atypical or adverse analytical findings

Research output: Contribution to journalJournal articlesResearchpeer-review

Standard

Harvard

APA

Vancouver

Bibtex

@article{f04f33c9e47e478288c4aa79cb3dc2d1,
title = "Do dried blood spots have the potential to support result management processes in routine sports drug testing? - Part 2: Proactive sampling for follow-up investigations concerning atypical or adverse analytical findings",
abstract = "Capillary blood sampled as dried blood spot (DBS) has shown substantial potential as test matrix in sports drug testing in various different settings, enabling the analysis of numerous different drugs and/or their respective metabolites. In addition to established beneficial aspects of DBS specimens in general (such as e.g. the minimally invasive and non-intrusive nature, simplified sample transport, etc.), a yet unexplored advantage of DBS in the anti-doping context could be the opportunity of preserving a source of information complementary to routine doping controls performed in urine or venous blood. Whenever follow-up investigations are warranted or required, frequently collected and stored (but yet not analyzed) DBS samples could be target-tested for the compound(s) in question, in order to contribute to results management and decision-making processes.",
author = "Mario Thevis and Tiia Kuuranne and Andreas Thomas and Hans Geyer",
note = "This article is protected by copyright. All rights reserved.",
year = "2021",
month = feb,
day = "4",
doi = "10.1002/dta.3011",
language = "English",
journal = "Drug testing and analysis",
issn = "1942-7603",
publisher = "John Wiley & Sons, Ltd",

}

RIS

TY - JOUR

T1 - Do dried blood spots have the potential to support result management processes in routine sports drug testing? - Part 2: Proactive sampling for follow-up investigations concerning atypical or adverse analytical findings

AU - Thevis, Mario

AU - Kuuranne, Tiia

AU - Thomas, Andreas

AU - Geyer, Hans

N1 - This article is protected by copyright. All rights reserved.

PY - 2021/2/4

Y1 - 2021/2/4

N2 - Capillary blood sampled as dried blood spot (DBS) has shown substantial potential as test matrix in sports drug testing in various different settings, enabling the analysis of numerous different drugs and/or their respective metabolites. In addition to established beneficial aspects of DBS specimens in general (such as e.g. the minimally invasive and non-intrusive nature, simplified sample transport, etc.), a yet unexplored advantage of DBS in the anti-doping context could be the opportunity of preserving a source of information complementary to routine doping controls performed in urine or venous blood. Whenever follow-up investigations are warranted or required, frequently collected and stored (but yet not analyzed) DBS samples could be target-tested for the compound(s) in question, in order to contribute to results management and decision-making processes.

AB - Capillary blood sampled as dried blood spot (DBS) has shown substantial potential as test matrix in sports drug testing in various different settings, enabling the analysis of numerous different drugs and/or their respective metabolites. In addition to established beneficial aspects of DBS specimens in general (such as e.g. the minimally invasive and non-intrusive nature, simplified sample transport, etc.), a yet unexplored advantage of DBS in the anti-doping context could be the opportunity of preserving a source of information complementary to routine doping controls performed in urine or venous blood. Whenever follow-up investigations are warranted or required, frequently collected and stored (but yet not analyzed) DBS samples could be target-tested for the compound(s) in question, in order to contribute to results management and decision-making processes.

U2 - 10.1002/dta.3011

DO - 10.1002/dta.3011

M3 - Journal articles

C2 - 33538088

JO - Drug testing and analysis

JF - Drug testing and analysis

SN - 1942-7603

ER -

ID: 5594439